Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma

Currently, the majority of patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) present with locally invasive and/or metastatic disease, resulting in five-year survival of less than 5%. The development of an early diagnostic test is, therefore, expected to significantly impact the patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Debernardi, Silvana, Massat, Nathalie J, Radon, Tomasz P, Sangaralingam, Ajanthah, Banissi, Ana, Ennis, Darren P, Dowe, Thomas, Chelala, Claude, Pereira, Stephen P, Kocher, Hemant M, Young, Bryan D, Bond-Smith, Giles, Hutchins, Robert, Crnogorac-Jurcevic, Tatjana
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697691/
https://ncbi.nlm.nih.gov/pubmed/26807325
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars